Heat Therapy and Peripheral Artery Disease
Heat Therapy for People with Peripheral Artery Disease: a Randomised Wait-List Controlled Feasibility Trial.
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of the study is to assess the efficacy of a novel 8 week heat therapy intervention in intermittent claudication compared to usual care controls. Participants will be enrolled on a wait-list control randomised trial testing physiological, mechanistic, and health related outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
February 14, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 20, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
February 14, 2025
February 1, 2025
2.6 years
February 4, 2025
February 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Maximum Walking Distance
Maximal walking distance a participant can walk, through a graded treadmill test.
Baseline to 8 weeks to 16 weeks
Pain Free Walking Distance
Maximum distance participant can walk without pain (IC)
Baseline to 8 weeks to 16 weeks
Time for Onset of Claudication
Amount of time able to walk pain free before reaching claudication
Baseline to 8 weeks to 16 weeks
Secondary Outcomes (12)
VascuQoL-6
Baseline to 8 weeks to 16 weeks
SF-36
Baseline to 8 weeks to 16 weeks
EQ-5D-5L
Baseline to 8 weeks to 16 weeks
Markers of Inflammation
Baseline to 8 weeks to 16 weeks
Markers of Vascular Remodelling
Baseline to 8 weeks to 16 weeks
- +7 more secondary outcomes
Other Outcomes (4)
Intervention feasibility assessed via recruitment rate
through study completion, an average of 1 year
Intervention feasibility assessed via protocol adherence
through study completion, an average of 1 year
Intervention acceptability via workshop interviews
through study completion, an average of 1 year
- +1 more other outcomes
Study Arms (2)
Wait-list control
NO INTERVENTIONUsual care 8 weeks
Heat Therapy Intervention
ACTIVE COMPARATORHeat therapy intervention through water submersion in a hot tub at \~40°C.
Interventions
Heat Therapy Intervention of shoulder depth submersion in a 40°C hot tub.
Eligibility Criteria
You may qualify if:
- Aged \> 18 years
- ABPI \< 0.9 at rest or a drop of 20mmHG after exercise testing
- Diagnosed with IC
- Able to walk unaided
- English-speaking and able to follow instructions
- No previous history of heat syncope
- Post-Menopausal or not on hormone therapy
- Able to provide informed consent
You may not qualify if:
- Walking impairment for a reason other than PAD
- Critical limb ischaemia/rest pain
- Asymptomatic PAD
- Active cancer treatment
- Clinically diagnosed diabetes or those with peripheral neuropathy
- Recent / frequent heat exposure (e.g., sauna or hot tubs).
- severe aortic stenosis, unstable angina, recent MI, stroke or TIA
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Manchester Metropolitan Universitylead
- British Heart Foundationcollaborator
Study Sites (1)
Manchester Metropolitan University
Manchester, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2025
First Posted
February 14, 2025
Study Start
May 1, 2025
Primary Completion (Estimated)
November 20, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
February 14, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share